今天，记者在湖南省县级公立医院眼科能力提升建设项目2025年度总结会上获悉，2021年10月至今，通 过该项目的落地，96家医院开展新技术，独立眼科由原来的3家增加到21家，14家医院设置眼科（含在 五官科内），63家医院新增眼底相机，我省基层眼科服务能力明显提升。 "针对前期调研发现我省基层医疗机构眼科缺人、缺设备、缺眼底病诊疗能力，导致很多老百姓在当地 无法得到及时诊治的情况，我们改变传统帮扶模式，通过AI赋能，利用项目经费为基层医疗机构提供 眼底相机，建立一分钟快速识别眼底病变和全身慢病的预警机制，在保障医疗服务水平的同时极大解决 了基层眼科医生匮乏和能力不足的问题。"湘雅二医院项目负责人罗静教授介绍，项目已累计完成AI辅 助阅片和远程会诊4万余人次，指导基层开展眼科手术300余台，使群众在县域内即可获得专家级诊疗方 案。我省"人工智能辅助诊断系统在基层致盲性眼病筛查中的作用"入选国家卫生健康委适宜技术推广备 选库。 会上 ，来自桃源县中医医院、石门县人民医院、祁阳市人民医院、湘乡市人民医院、慈利县中医医 院、新宁县人民医院、宁乡市中医医院、隆回县人民医院等优秀项目单位代表，围绕学科建设路径、人 才梯队 ...

Core Insights - The article highlights the increasing participation of domestic medical equipment in the ophthalmology sector, particularly in basic examinations, auxiliary diagnostics, AI imaging, and surgical support equipment, indicating a shift towards domestic and AI-driven solutions in the market [1][3]. Summary by Sections Market Trends - The procurement trends for the second half of the year will focus on domestic production, AI integration, and penetration into lower-tier markets [1]. Procurement Overview - In the past week, there were 13 different procurement units involved, including top-tier hospitals and county-level hospitals, indicating a diverse range of buyers [3]. - The procurement involved nearly 20 different types of ophthalmic equipment, covering basic examination tools, imaging and diagnostic devices, and surgical treatment instruments [3]. Brand Participation - A total of 22 brands were involved in the procurement, with domestic brands accounting for nearly 60% of the total, showcasing the growing influence of local manufacturers [3]. Financial Highlights - The total bid amount reached 18.743 million yuan, with the highest single equipment bid amounting to 3.2779 million yuan, reflecting significant investment in ophthalmic technology [3].

Group 1 - The core point of the article is that Gaoshi Medical's subsidiary, Gaoshi Innovation Technology Co., Ltd., has received approval from the Jiangsu Provincial Drug Administration for its "fundus camera" medical device [1] - The fundus camera integrates an intelligent imaging system with innovative non-mydriatic high-definition imaging technology, achieving fully automated operation [1] - The fundus camera is suitable for screening, diagnosing, and long-term follow-up of various fundus diseases, including diabetic retinopathy, promoting the popularization of eye health screening [1]

Core Viewpoint - The eye health awareness among the Chinese population is increasing, leading to significant growth in the ophthalmic optical instrument industry, which is expected to reach a market size of approximately 4 billion yuan by 2024 [1][15]. Industry Overview - Ophthalmic optical instruments are essential for diagnosing and treating eye diseases, including devices like computer visual field analyzers, automatic refractors, corneal topographers, and fundus cameras [3][4]. - The industry has seen remarkable advancements in technology and product development, with domestic companies enhancing their R&D capabilities and launching high-quality products [1][15]. Market Growth - The market size of China's ophthalmic optical instrument industry has been continuously growing from 2017 to 2023, with projections indicating it will reach around 4 billion yuan in 2024 [1][15]. - The increasing prevalence of age-related eye diseases and lifestyle changes, such as prolonged use of electronic devices, are driving the demand for ophthalmic medical services [13][25]. Industry Chain - The upstream of the ophthalmic optical instrument industry includes suppliers of optical glass and plastic, which are crucial for manufacturing high-quality instruments [9][11]. - The midstream consists of various manufacturers of ophthalmic optical instruments, while the downstream includes hospitals, clinics, and optical shops where these instruments are utilized [9]. Competitive Landscape - The market concentration in the ophthalmic optical instrument industry is relatively high, with a few companies dominating specific product areas like fundus cameras and OCT devices [17][18]. - Key players in the industry include companies like 图拜医疗, 康捷医疗, and 新眼光, which are focusing on high-end product development [17][18]. Policy Environment - Recent policies have been introduced to promote the standardization and regulation of the medical device industry, providing favorable conditions for the growth of the ophthalmic optical instrument sector [4][6]. - The government aims to enhance the quality and safety of medical devices, ensuring a robust regulatory framework by 2035 [6]. Future Trends - The market is expected to further penetrate various healthcare institutions, with handheld devices likely to see widespread adoption in grassroots medical facilities [23]. - The integration of artificial intelligence and big data into ophthalmic optical instruments is becoming mainstream, leading to the development of smart devices that enhance diagnostic capabilities [24][25].